Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2020-08-21 2020-08-21
Drug Identification Number 02253577 02253577
Brand name MEDROXY-5 MEDROXY-5
Common or Proper name MEDROXY MEDROXY
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code G03DA G03DA
ATC description PROGESTOGENS PROGESTOGENS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-08-31 2020-08-31
Actual discontinuation date 2020-08-20 2020-08-20
Remaining supply date 2021-01-31 2021-01-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments